For Oppenheimer, Broadcom (AVGO) is a core AI name and remains a top AI pick. Seeking Alpha analysts at large consider AVGO a Buy. This compares with average Wall Street rating of Buy and SA Quant ...

The managers have had long-term success with Invesco Core Plus Bond since 2013 ... legacy teams from Invesco and 2019 acquisition OppenheimerFunds have deepened their collaboration; for instance ...

"Gadget," the first atomic bomb — a 6-foot sphere with a grapefruit-sized Plutonium core, covered in cables ... and American physicist J. Robert Oppenheimer. You might recognize ...

Oppenheimer reiterated its Outperform rating on AppLovin Corp (NASDAQ:APP), currently trading at $384.40, with a consistent ...

Oppenheimer analyst Suraj Kalia lowered the firm’s price target on Varex Imaging (VREX) to $23 from $30 and keeps an Outperform rating on the ...

The company’s core objective is to leverage its proprietary Phospholipid Drug Conjugate™ (PDC) delivery platform to develop the next-generation of cancer cell-targeting treatments, delivering ...

Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva ...

Oppenheimer's analysis highlights Citigroup's journey since the Global Financial Crisis (GFC), noting that from 2012 to 2023, Citigroup's core Return on Tangible Common Equity (ROTCE) averaged 9.2 ...